Prudential Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Prudential Financial’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Sell	14,720 -1,775	-11%	-$178K	﹤0.01%	1449
2026 Q1	$1.52M	Sell	16,495 -33,605	-67%	-$3.16M	﹤0.01%	1434
2025 Q4	$3.96M	Sell	50,100 -4,085	-8%	-$293K	﹤0.01%	1016
2025 Q3	$3.97M	Buy	54,185 +44,540	+462%	+$2.83M	﹤0.01%	1047
2025 Q2	$491K	Buy	+9,645	New	+$429K	﹤0.01%	1948
2022 Q4	–	Sell	-105,335	Closed	-$2.21M	–	2670
2022 Q3	$2.21M	Sell	105,335 -56,585	-35%	-$1.36M	﹤0.01%	1278
2022 Q2	$3.15M	Buy	161,920 +81,620	+102%	+$1.93M	0.01%	1130
2022 Q1	$1.77M	Buy	80,300 +16,270	+25%	+$332K	﹤0.01%	1564
2021 Q4	$1.02M	Buy	+64,030	New	+$996K	﹤0.01%	1869

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's MIRM Position: Q2 2026 in Review

Prudential Financial reduced its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, selling an estimated $178K and leaving 14,720 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Prudential Financial first reported a position in MIRM in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.97M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Prudential Financial held 14,720 shares of Mirum Pharmaceuticals worth $1.72M as of Q2 2026.
Prudential Financial sold 1,775 Mirum Pharmaceuticals shares in Q2 2026, an estimated $178K.
Mirum Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1449 holding.
Prudential Financial first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Prudential Financial's Mirum Pharmaceuticals position peaked at $3.97M in Q3 2025.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.